LSV Asset Management
AMAG

LSV Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History

LSV Asset Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,119,598
Closed -$14.8M – 1004
2017
Q4 		$14.8M Sell
1,119,598
-364,300
-25% -$5.49M 0.02% 430
2017
Q3 		$27.4M Sell
1,483,898
-194,200
-12% -$3.62M 0.05% 314
2017
Q2 		$30.9M Sell
1,678,098
-7,000
-0.4% -$139K 0.06% 293
2017
Q1 		$38M Buy
1,685,098
+427,238
+34% +$10.2M 0.07% 252
2016
Q4 		$43.8M Buy
1,257,860
+878,523
+232% +$26.2M 0.08% 243
2016
Q3 		$9.3M Buy
379,337
+110,500
+41% +$2.76M 0.02% 447
2016
Q2 		$6.43M Buy
268,837
+169,195
+170% +$3.88M 0.01% 486
2016
Q1 		$2.33M Buy
99,642
+5,800
+6% +$138K ﹤0.01% 634
2015
Q4 		$2.83M Buy
93,842
+15,600
+20% +$504K 0.01% 593
2015
Q3 		$3.11M Buy
+78,242
New +$4.86M 0.01% 565

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LSV Asset Management's AMAG Position: Q1 2018 in Review

LSV Asset Management sold out of AMAG Pharmaceuticals (AMAG) in Q1 2018, closing a stake of 1,119,598 shares — an estimated $14.8M sold.

LSV Asset Management first reported a position in AMAG in Q3 2015 and held it in 10 quarters. The position peaked at $43.8M in Q4 2016. 170 funds tracked by Wall St. Rank hold AMAG as of Q1 2018.

  • LSV Asset Management reported no remaining AMAG Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • LSV Asset Management sold 1,119,598 AMAG Pharmaceuticals shares in Q1 2018, an estimated $14.8M.
  • LSV Asset Management first reported a position in AMAG Pharmaceuticals in Q3 2015 and held it in 10 quarters.
  • LSV Asset Management's AMAG Pharmaceuticals position peaked at $43.8M in Q4 2016.
  • 170 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2018.

Based on LSV Asset Management's 13F filing for Q1 2018, filed 4 May 2018.